Daily non-political popular news in brief.

Survival shortened when ER/PR negative breast cancer spreads to the brain

Two studies from Mayo Clinic's site in Jacksonville, Fla., of women whose breast cancer spread to their brain, have found that women whose tumors do not have estrogen or progesterone receptors have the worst overall outcomes. Because of this, these patients should be treated aggressively after an initial diagnosis to help prevent such a metastasis, say the investigators, who presented their findings at the San Antonio Breast Cancer Symposium.

Read more »

Keywords: survival, shortened, negative, breast, cancer, spreads, brain, spread

« Previous | Next »

Similar news on "Survival shortened when ER/PR negative breast cancer spreads to the brain":

1. Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer
   11-01-2007 · EurekAlert!
   A Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer.
   Similar news · Read more »
   
2. Anthracyclines improve survival in HER2-positive breast cancer patients
   12-25-2007 · EurekAlert!
   Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online Dec. 25 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
3. Novel regulation of the common tumor suppressor PTEN
   01-11-2007 · EurekAlert!
   PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the prostate, breast, colon and brain. Researchers led by scientists at Memorial Sloan-Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the Jan. 12 issue of Cell.
   Similar news · Read more »
   
4. Antibody extends life of mice with breast cancer
   12-11-2006 · EurekAlert!
   A monoclonal antibody developed by researchers at the University at Buffalo has been shown to extend significantly the survival of mice with human breast-cancer tumors and to inhibit the cancer's spread to the lungs in the animals by more than 50 percent.
   Similar news · Read more »
   
5. Taxol-type drugs give slight boost to survival rates in early breast cancer
   10-16-2007 · EurekAlert!
   The breast cancer drugs called taxanes, which include taxol and taxotere, increase survival rates when used as part of chemotherapy following surgery for cancers that have not spread, according to a new review of the research.
   Similar news · Read more »
   
6. Treatment capitalizes on unique qualities of radioisotope to prolong lives of brain tumor patients
   01-30-2008 · EurekAlert!
   In a study to determine safe dosages of the isotope astatine-211 for patients with recurring brain tumors, researchers were pleasantly surprised to find that not only was the isotope's potency sufficient to kill residual cancer cells without damaging sensitive healthy brain cells, but the patients experienced longer survival rates.
   Similar news · Read more »
   
7. Women testing negative for familial breast cancer gene still at increased risk
   10-30-2006 · EurekAlert!
   Women testing negative for the two inherited breast cancer genes are still at increased risk of developing the disease, suggests research published ahead of print in the Journal of Medical Genetics.
   Similar news · Read more »
   
8. Epigenetic drugs, promising for breast cancer treatment
   12-20-2006 · EurekAlert!
   Worldwide, cancer persists as one of the most important diseases that affect the human being. The knowledge on the molecular bases of cancer generated during the last decades has been successfully translated into small but significant gains in overall cancer survival rates due to better primary prevention measures, improved diagnostic methods and the development of more effective and specific therapies, collectively termed "molecular targeted therapies." In the context of these new forms of treatment, epigenetic or transcriptional cancer therapy is clearly promising.
   Similar news · Read more »
   
9. Other highlights from the March 21 JNCI
   03-20-2007 · EurekAlert!
   Also in the March 21 JNCI are a study on the link between fat intake and breast cancer risk, a plant compound that may decrease breast cancer risk, a critique of the use of progression-free survival in cancer clinical trials, and a mutation to a mismatch repair gene that is associated with colorectal cancer.
   Similar news · Read more »
   
10. Preoperative chemotherapy is a safe option for women with early stage operable breast cancer
    04-17-2007 · EurekAlert!
    Chemotherapy is frequently given to women with breast cancer after surgery to remove the main bulk of the tumor. A new Cochrane Systematic Review of existing data shows, however, that using chemotherapy to reduce the size of tumors before surgery does not compromise survival rates and enables women to retain better self-image and overall health because of the reduced impact of the surgery.
    Similar news · Read more »